Skip to content
Open access

MULTI-TARGET MECHANISTIC INSIGHTS INTO GARLICMEDIATED NEUROPROTECTION IN ALZHEIMER’S DISEASE USING NETWORK PHARMACOLOGY, MOLECULAR DOCKING, AND IN VITRO VALIDATION

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations

TL;DR

This study shows that Allium sativum has the ability to modulate important proteins and signaling pathways linked to cognitive impairment, neurodegeneration, inflammation, and oxidative stress, suggesting that it could be a natural treatment option for Alzheimer's disease.

Abstract

Molecular docking, in vitro cell line study, network pharmacology, and molecular dynamics (MD) simulations are all used to assess Allium sativum's anti-Alzheimer potential in this research. The molecular pathways linked to Alzheimer's disease (AD) remain poorly understood, despite the widespread use of Allium sativum in traditional medicine for its antioxidant and neuroprotective effects. Allicin, alliin, ajoene, diallyl sulfide, and S-allyl cysteine were among the main bioactive components found during phytochemical screening. Some common targets linked to Alzheimer's disease were identified by target prediction and disease-gene mapping studies based on these phytochemicals. Several biochemical pathways related to cholinergic neurotransmission may be regulated by Allium sativum, according to protein-protein interaction (PPI) and enrichment studies, oxidative stress, neuroinflammation, amyloid-beta metabolism, and tau protein regulation. “The molecular docking studies showed that certain phytoconstituents had much stronger binding affinities than the standard therapeutic agents for several important Alzheimer's-related targets, such as acetylcholinesterase (AChE), butyrylcholinesterase (BChE), amyloid precursor protein (APP), and microtubule-associated protein tau (MAPT). In addition, the MD simulations showed that the protein-ligand interactions were stable and that the conformational dynamics were favorable, which might have biological implications and modulate the target. An in vitro acetylcholinesterase inhibition study confirmed the neuroprotective potential of garlic extract, complementing the computational findings. The extract showed substantial enzyme inhibitory activity that was on par with that of conventional inhibitors. In conclusion, this study shows that Allium sativum has the ability to modulate important proteins and signaling pathways linked to cognitive impairment, neurodegeneration, inflammation, and oxidative stress, suggesting that it could be a natural treatment option for Alzheimer's disease.

Read PDF

Similar papers

Open access Oct 2026

Phytochemical Network Pharmacology in Alzheimer's disease: Multi-Target Neuroprotective Strategies and Emerging Drug Delivery Approaches

This integrated approach constructs compound target-disease-pathway interactomes, showing polypharmacological synergy in modulating key hubs involved in APP, GSK-3β, NF-κB, PI3K/Akt, and MAPK cascades, thus inhibiting Aβ plaque deposition, tau pathology, microglial activation, apoptosis, and improving neurotrophic supp...

R. Venisetty · 0 citations
Open access Nov 2026

Systems Pharmacology and Molecular Docking-Based Investigation of the Molecular Mechanism of Astilbin in the Treatment of Alzheimer's Disease.

This study combined systems pharmacology and computational biology to systematically investigate the multi-target mechanisms and network features of Astilbin, a natural flavonoid glycoside, in Alzheimer's disease (AD) intervention. We collected potential targets of astilbin and AD-associated genes from PharmGKB, GeneCa...

Si-Qi Huang, Quan-Zhou Lv, Liang-Chong Chen et al. · 0 citations
Open access Sep 2026

Multi-target modulation of the neuroinflammatory network by asiatic acid in ischemic stroke: Integrated network pharmacology, molecular docking, and in vitro validation 

Findings support a hypothesis in which AA modulates an interconnected neuroinflammatory and stress-response network rather than a single molecular target, expanding the therapeutic rationale for AA in ischemic stroke while defining specific targets and pathways for future mechanistic investigation.

Jun-jun Gong, Kok-Hong Tang · 0 citations
Oct 2026

Integrating Network Pharmacology and Experimental Validation to Elucidate the Anti-neuroinflammatory Mechanism of Hemerocallis citrina Baroni Against Alzheimer's Disease.

INTRODUCTION Alzheimer's Disease (AD) is a major global health challenge owing to its increasing prevalence, devastating clinical consequences, and the lack of therapeutic interventions. The flower buds of Hemerocallis citrina Baroni (HBF), a traditional herbal medicine and functional food in China, possess diverse neu...

Meng-Jie Xu, Yi-Lin Zhang, Wei-Rong Jie et al. · 0 citations
Oct 2026

Study on the Mechanism of Ginkgetin's Anti-alzheimer's Disease Effects Based on Network Pharmacology and Experimental Validation

Ginkgetin (GIN) has been reported to exhibit antioxidant and antiinflammatory activities, but its role in Alzheimer's Disease (AD) remains underexplored. This study aimed to systematically investigate the mechanisms of GIN in AD by integrating network pharmacology for target prediction with molecular docking, behav...

Xin-Juan Liu, Ting Yu, Mei-Fang Jiang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.